We are live on
!
Find out more
EPGL
Evelyn Partners Group Ltd Portfolio holdings
AUM
$46.9B
This Fund
S&P 500
This Quarter
Est. Return
-2.15%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$46.9B
AUM Growth
–
Cap. Flow
+$5.86B
Cap. Flow
% of AUM
12.5%
Top 10 Holdings %
Top 10 Hldgs %
93.6%
Holding
551
New
551
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$421M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$409M |
| 3 |
Amazon
AMZN
|
+$395M |
| 4 |
Microsoft
MSFT
|
+$378M |
| 5 |
NVIDIA
NVDA
|
+$261M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 89.62% |
| 2 | Technology | 2.91% |
| 3 | Financials | 2.09% |
| 4 | Communication Services | 1.32% |
| 5 | Consumer Discretionary | 1.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
426
Kirby Corp
KEX
$6.93B
| $23.8K | ﹤0.01% |
+175
| New | +$25K |
|
427
First Trust Large Cap Core AlphaDEX Fund
FEX
$1.61B
| $23.8K | ﹤0.01% |
+170
| New | +$22.5K |
|
428
Diamondback Energy
FANG
$52.7B
| $23.4K | ﹤0.01% |
+133
| New | +$25.8K |
|
429
Vertex Pharmaceuticals
VRTX
$126B
| $23.3K | ﹤0.01% |
+47
| New | +$20.8K |
|
430
Manchester United
MANU
$3.73B
| $22.6K | ﹤0.01% |
+985
| New | +$19.5K |
|
431
First Trust Preferred Securities and Income ETF
FPE
$6.36B
| $22.4K | ﹤0.01% |
+1,250
| New | +$22.5K |
|
432
Republic Services
RSG
$65.7B
| $22.2K | ﹤0.01% |
+104
| New | +$21.7K |
|
433
Datadog
DDOG
$84B
| $21.9K | ﹤0.01% |
+84
| New | +$15.6K |
|
434
PIMCO Dynamic Income Fund
PDI
$7.42B
| $21.6K | ﹤0.01% |
+1,291
| New | +$21.9K |
|
435
Moderna
MRNA
$23.6B
| $21.3K | ﹤0.01% |
+304
| New | +$15.7K |
|
436
Pultegroup
PHM
$25.3B
| $21.1K | ﹤0.01% |
+154
| New | +$18.7K |
|
437
MetLife
MET
$62.1B
| $20K | ﹤0.01% |
+236
| New | +$19K |
|
438
NovaGold Resources
NG
$3.33B
| $19.1K | ﹤0.01% |
+3,200
| New | +$26.6K |
|
439
SBA Communications
SBAC
$19.5B
| $18.7K | ﹤0.01% |
+106
| New | +$21.9K |
|
440
News Corp Class A
NWSA
$15.4B
| $18.7K | ﹤0.01% |
+752
| New | +$19.5K |
|
441
Sempra
SRE
$54.8B
| $18.5K | ﹤0.01% |
+200
| New | +$18.6K |
|
442
Cloudflare
NET
$107B
| $18.4K | ﹤0.01% |
+75
| New | +$16.4K |
|
443
Warner Bros
WBD
$67.1B
| $18.3K | ﹤0.01% |
+686
| New | +$18.6K |
|
444
Columbia India Consumer ETF
INCO
$239M
| $17.9K | ﹤0.01% |
+300
| New | +$17.6K |
|
445
Brown & Brown
BRO
$23.9B
| $17.6K | ﹤0.01% |
+275
| New | +$16.8K |
|
|
EMF
446
Templeton Emerging Markets Fund
EMF
$326M
| $17.4K | ﹤0.01% |
+750
| New | +$16.2K |
|
447
Verisk Analytics
VRSK
$25B
| $17.4K | ﹤0.01% |
+97
| New | +$17.1K |
|
448
Icon
ICLR
$12.7B
| $17.4K | ﹤0.01% |
+100
| New | +$12.7K |
|
449
Pan American Silver
PAAS
$21.6B
| $17.2K | ﹤0.01% |
+383
| New | +$20.5K |
|
|
FTHY
450
First Trust High Yield Opportunities 2027 Term Fund
FTHY
$498M
| $17.1K | ﹤0.01% |
+1,250
| New | +$16.9K |
|
Similar funds
TI
LP
RIM
Evelyn Partners Group Ltd's Q2 2026 Portfolio in Review
Q2 2026 is the first quarter with a 13F filing on record for Evelyn Partners Group Ltd, which disclosed 551 positions worth $46.9B. Its ten largest holdings account for 94% of the portfolio.
Its largest position is AstraZeneca: 2,237,205 shares worth $41.5B.
By sector, the portfolio is most concentrated in Healthcare at 90% of assets, followed by Technology and Financials.
- Evelyn Partners Group Ltd's largest Q2 2026 buy was AstraZeneca: 2,237,205 shares worth $41.5B.
- Evelyn Partners Group Ltd's ten largest holdings make up 94% of its $46.9B portfolio in Q2 2026.
- Evelyn Partners Group Ltd disclosed 551 positions in Q2 2026, its first 13F filing on record.
Based on Evelyn Partners Group Ltd's 13F filing for Q2 2026, filed 7 Aug 2026.